Nuveen’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,809
Closed -$310K 3577
2022
Q1
$310K Buy
4,809
+80
+2% +$6.66K ﹤0.01% 3119
2021
Q4
$685K Sell
4,729
-348
-7% -$58.8K ﹤0.01% 2981
2021
Q3
$847K Sell
5,077
-343
-6% -$68K ﹤0.01% 3048
2021
Q2
$1.49M Buy
5,420
+2,095
+63% +$529K ﹤0.01% 2842
2021
Q1
$712K Buy
3,325
+542
+19% +$150K ﹤0.01% 3002
2020
Q4
$672K Buy
2,783
+279
+11% +$34.5K ﹤0.01% 2943
2020
Q3
$264K Buy
2,504
+876
+54% +$79.8K ﹤0.01% 3108
2020
Q2
$160K Sell
1,628
-210
-11% -$18.4K ﹤0.01% 3127
2020
Q1
$138K Buy
1,838
+118
+7% +$11.2K ﹤0.01% 3042
2019
Q4
$140K Hold
1,720
﹤0.01% 3102
2019
Q3
$210K Sell
1,720
-125
-7% -$17.2K ﹤0.01% 3116
2019
Q2
$331K Buy
+1,845
New +$298K ﹤0.01% 3104

Other funds holding EVLO